Study in France suggests high efficacy of mRNA vaccines against SARS-CoV-2 variants of concern

By | July 22, 2021
A nationwide case-control study conducted in France has assessed the efficacy of mRNA-based coronavirus disease 2019 (COVID-19) vaccines against original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, including B.1.1.7, B.1.351, and P1.